It was reported to boston scientific corporation that an obtryx ii system - halo was implanted during a procedure performed on (b)(6) 2018.According to the complainant, on (b)(6) 2018, the patient began to experience recurrent urinary tract infections (uti), and as the year progressed, the time between each uti became shorter.After suffering on her 7th time of having uti, the patient was prescribed with an ongoing low-dose course of antibiotics.Since the surgery, the patient also felt an increased urge to urinate, even though her bladder was far from full.Moreover, after undergoing the cystoscopy and ureteroscopy procedures, the patient was diagnosed with a hypersensitive bladder and abnormally slow voiding, which she neither had these conditions prior the surgery.The patient also noticed an overall decline of her health, suffering from crashing fatigue, flu-like symptoms after minimal exertion, breathlessness, dizziness and crippling panic attacks.These symptoms began towards the end of 2018.Despite quitting her job and minimizing her activities as much as possible, while improving her diet and taking steps to improve her health, the patient still noticed a steady decline of health.Also, intercourse with her partner has been painful since the surgery and has not improved over the period of 2 years.Reportedly, there were no steps have been taken to address the issue.
|